The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Good contracts, nice pipeline ,increase in revenue, and several million in the bank. Like !
Plus amati just taken 10%
Under the radar.
Charles Spicer, Chairman, bought 60,606 shares in the company on the 23rd May 2018 at a price of 33.00p. Ixico halves first-half losses as revenue rises 30% - Digital technologies group Ixico operating losses more than halved in the six months to the end of March
below the radar.
got a feeling this will do well too.
Hi Thoth, yes very quiet, I have been invested here for quite some time and have built up a decent holding. I think that the share is very much under the radar and not very well known. I met most of the directors at the Agm in January and liked what they had to say. There was a trading statement on 21st Oct last year so we could have an update quite soon. Have a look at their Twitter link, a few interesting new positions advertised recently. Good luck.
I have a few but v quiet board here ???
Great results, great interview with CEO on Proactive. A lot to look forward to.
3 times higher 3 months average. Contract win. Good balance sheet. Interesting company
Hi Goldust, i do not think that there are too many shares freely available, which will work well if we have good news and as you say the reverse if we have bad news, I think that someone had been selling for the past few months and this brought the price down. I feel that the price should be a bit higher yet and I am hoping that we get news of improved trading due to revenue from the trials announced lasy year building. I was expecting a trading statement this week as it was announced on 19th Oct last year but may have been delayed as Dereck Hill is addressing the conference in Washington and he would probably prefer to be here.
Market makers pushing price up on tiny trades-will go up quick and often down again fast, very difficult to trade..
I like it Dereck Hill is presenting at The Coalition Against Major Diseases in Washington, he commented. Biosensor technologies are set to revolutionise drug development and patient care when used in the appropriate clinical context and regulatory framework. Ixico is delighted to share our cutting-edge work with regulators and experts in the pharmaceutical industry.
Another nice contract announced today. There was a trading statement on 19th Oct last year so lets hope for more news next week. Prior to this they had nine early stage contracts so revenue should be building.
I cleared out my holding here just because of another opportunity (luckily before the drop). I would have thought it should be red hot for a takeover by the likes of IBM for its medical imaging analytics etc. very surprised at the SP. will be back in
Someone selling, it does not take many to push the price down, also it does not take many to push the price up. Should be a trading statement in about a month, early stage of nine trials with revenue building and a great announcement today, liked the last bit on RNS, prior to production rollout. Working with Biogen a $66 billion market cap company
anyone got a clue why the sp has been dropping
More excellent progress looks like there should be good progress in second half.
In next few days, fingers crossed
Another contract for IXICO they are really motoring and no one seems to have noticed them yet. Well undervalued in my opinion